Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Turkey / NCT07861698
Starting soon Observational

Turkish Version of a Scale Measuring How People View Chronic Pain

NCT07861698 · tracked via the Priya Life Science Turkey tracker
Sponsor
Bilecik Seyh Edebali Universitesi
Phase
Observational
Started
2026-12-15
Last updated
2026-10-13

Condition(s) studied

Chronic Pain

Study summary

This study will translate and culturally adapt the Patients' Endorsement of a Biopsychosocial Model of Chronic Pain Scale (PEB) into Turkish and evaluate how well and consistently it measures the views of adults with chronic pain. The study will take place at the Physical Medicine and Rehabilitation outpatient clinic of Bilecik Training and Research Hospital. At least 200 adults will be included in the main sample. Participants will complete questionnaires that are expected to take 10 to 15 minutes. An additional 20 people who will not be included in the main sample will take part in a pilot assessment. Fifty participants from the main sample will complete the PEB Scale again after two weeks. No treatment or intervention will be assigned.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Aged 18 years or older. * Voluntarily agrees to participate in the study. * Has physician-diagnosed chronic pain lasting or recurring for more than 3 months. * Able to read and write Turkish. * Has sufficient cognitive ability to understand and complete the data collection forms. Exclusion Criteria: * Presents with acute pain or does not meet the chronic pain criteria. * Has a cognitive or communication impairment that prevents completion of the data collection forms. * Submits incomplete data collection forms.

Primary outcome measure(s)

  • Construct validity and internal consistency of the Patients' Endorsement of a Biopsychosocial Model of Chronic Pain Scale — At the initial assessment (single administration)
    The Patients' Endorsement of a Biopsychosocial Model of Chronic Pain Scale (PEB Scale) consists of 11 items rated on a 4-point scale (1-4), yielding a total score of 11-44. Higher scores indicate stronger endorsement of the biopsychosocial model of chronic pain and represent a more favorable outcome. Construct validity will be evaluated using exploratory and confirmatory factor analyses. Internal consistency will be assessed using Cronbach's alpha and corrected item-total correlations.

Trial sites (1)

FacilityCityRegionStatus
Bilecik Eğitim ve Araştırma Hastanesi Bilecik Turkey (Türkiye)

More Bilecik Seyh Edebali Universitesi trials in Turkey

The Role of Pain Catastrophizing, Resilience, and Illness Perception in Predicting Fibromyalgia Impact in Patients With Fibromyalgia Enrolling by invitation
Botulinum Toxin-A for Bruxism Using Digital Occlusal Analysis Starting soon
The Impact of Professional Holistic Competence, Professional Pride, and Organizational Spirituality on Quiet Quitting Among Intensive Care Nurses Enrolling by invitation
The Effect of Retirement Education on Individuals' Retirement Planning and Quality of Life Starting soon
Neuropathic Pain and Type II Diabetic Patients Active, not recruiting

Other trials for the same condition

Effects of Low Back Pain Types on Pain Severity and Quality of Life in Patients With Failed Back Surgery Syndrome Recruiting
Turkish Validation of the Geriatric Pain Measure - Short Form Recruiting
Validation of the Turkish Brief Inventory of Treatment Expectations in Chronic Pain Recruiting
Efficacy of Transcutaneous Pulsed Radiofrequency in Postherpetic Neuralgia Recruiting
One Cause of Heel Pain is Plantar Fasciopathy (PF). In Most Cases, a Heel Spur is Frequently Present Alongside PF. We Aim to Evaluate the Efficacy of Corticosteroid Injection and Radiofrequency Ablation, Along With Tissue Elasticity Assessed by Ultrasound, in Patients With Chronic Pain (≥6 Months). Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07861698 on ClinicalTrials.gov ↗ ← All trials in Turkey